^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CM-728

i
Other names: CM-728, CM728, CM 728
Associations
Trials
Company:
Ceamed
Drug class:
Apoptosis stimulant, STAT3 inhibitor
Related drugs:
Associations
Trials
over1year
Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer. (PubMed, Int J Biol Sci)
Furthermore, CM728 exerted a strong synergistic antiproliferative effect with docetaxel in vitro and this combination was more effective than the individual treatments in vivo. Taken together, our results identify a novel compound with antitumoral properties against TNBC. In addition, we describe the mechanism of action of this drug and provide a rationale for the use of Prdx1 inhibitors, such as CM728, alone or in combination with other drugs, for the treatment of TNBC.
Journal
|
PRDX1 (Peroxiredoxin 1)
|
docetaxel • CM-728